158 related articles for article (PubMed ID: 2504308)
1. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.
Heslop HE; Gottlieb DJ; Bianchi AC; Meager A; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
Blood; 1989 Sep; 74(4):1374-80. PubMed ID: 2504308
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation.
Heslop HE; Price GM; Prentice HG; Cordingley FT; Webster AD; Hoffbrand AV; Brenner MK
J Immunol; 1988 May; 140(10):3461-6. PubMed ID: 3283234
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy.
Heslop HE; Gottlieb DJ; Reittie JE; Bello-Fernandez C; Meager A; Prentice HG; Brenner MK
Br J Haematol; 1989 Jun; 72(2):122-6. PubMed ID: 2503022
[TBL] [Abstract][Full Text] [Related]
4. IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma.
Bello-Fernandez C; Oblakowski P; Meager A; Duncombe AS; Rill DM; Hoffbrand AV; Brenner MK
Immunology; 1991 Feb; 72(2):161-6. PubMed ID: 1901829
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation.
Heslop HE; Duncombe AS; Reittie JE; Bello-Fernandez C; Gottlieb DJ; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
Br J Haematol; 1991 Feb; 77(2):237-44. PubMed ID: 2004026
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy.
Gottlieb DJ; Prentice HG; Heslop HE; Bello-Fernandez C; Bianchi AC; Galazka AR; Brenner MK
Blood; 1989 Nov; 74(7):2335-42. PubMed ID: 2804369
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia.
Murohashi I; Hoang T
Blood; 1991 Aug; 78(4):1085-95. PubMed ID: 1714325
[TBL] [Abstract][Full Text] [Related]
8. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
[TBL] [Abstract][Full Text] [Related]
9. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.
Reittie JE; Gottlieb D; Heslop HE; Leger O; Drexler HG; Hazlehurst G; Hoffbrand AV; Prentice HG; Brenner MK
Blood; 1989 Apr; 73(5):1351-8. PubMed ID: 2495037
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies.
Higuchi CM; Thompson JA; Petersen FB; Buckner CD; Fefer A
Blood; 1991 Jun; 77(12):2561-8. PubMed ID: 2043762
[TBL] [Abstract][Full Text] [Related]
11. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
Chong AS; Scuderi P; Grimes WJ; Hersh EM
J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506
[TBL] [Abstract][Full Text] [Related]
12. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
13. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
[TBL] [Abstract][Full Text] [Related]
14. Rapid cytokine release in cancer patients treated with interleukin-2.
Weidmann E; Bergmann L; Stock J; Kirsten R; Mitrou PS
J Immunother (1991); 1992 Aug; 12(2):123-31. PubMed ID: 1504053
[TBL] [Abstract][Full Text] [Related]
15. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
Le JM; Vilcek J
J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
[TBL] [Abstract][Full Text] [Related]
17. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
18. Cytokine production in whole blood cell cultures of patients undergoing therapy with biological response modifiers or 5-fluorouracil.
Elsässer-Beile U; von Kleist S; Lindenthal A; Birken R; Gallati H; Mönting JS
Cancer Immunol Immunother; 1993 Aug; 37(3):169-74. PubMed ID: 8334680
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous cytokine production and its effect on induced production.
Walker D; Jason J; Wallace K; Slaughter J; Whatley V; Han A; Nwanyanwu OC; Kazembe PN; Dobbie H; Archibald L; Jarvis WR
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1049-56. PubMed ID: 12204958
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
